Frost & Sullivan

JULY 22, 2021

As a result, academic labs and small biotech companies are accelerating RNA therapeutics research, alongside Tier 1 biopharmaceutical companies.” The post Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe appeared first on Frost & Sullivan.

Biotech 98

Biotech Biopharmaceuticals Biotechnology Government 98

Jake Jorgovan

FEBRUARY 1, 2024

Herspiegel Consulting : Recognized for its excellence in commercial strategy, Herspiegel Consulting focuses on innovative solutions for pharmaceutical and biotech companies, with a strong track record in product launches and commercial execution. Supporting biotech companies from early-stage funding to international market launches.

Life science 130

Life science Biotech Biotechnology Engineering 130

Frost & Sullivan

MARCH 22, 2024

However, the pharma/biopharma industry shows overall stagnant R&D activity. Small-to-mid and emerging biopharma players contribute over 16%. As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. billion, with a modest 2.5%

Ecosystems 52

Ecosystems Biopharma Biotech Contract research organization 52

Frost & Sullivan

APRIL 21, 2021

2 – The consolidation of PPD with TMO’s Patheon manufacturing unit creates a compelling end-to-end offering for biopharma sponsors and an opportunity to cross-sell services through revenue stream synergies. TMO recorded the highest top-line Y-o-Y revenue growth of over 26% in 2020 in comparison to the last five years.

Biopharma 98

Biopharma Biotech Banking 98

Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A).

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

Frost & Sullivan

DECEMBER 8, 2022

TrialWire provides clinical trial patient recruitment for biotechs, pharma and CROs with state-of-the-art artificial intelligence (AI) powered software and advanced algorithms. TrialWireä is HIPAA compliant and uses the most advanced technologies to solve the patient recruitment crisis for biopharma.

Biotech 52

Biotech Life science Biopharma 52

Frost & Sullivan

DECEMBER 13, 2022

VeriSIM Life provides insights to pharma, biotech, academia, and research institutions and conducts risk-sharing collaborations to develop promising drugs, paving the preclinical development roadmap with AI. VeriSIM Life develops and implements a hybrid, tailored customer service approach: professional services and software-as-a-service.

Biopharma 52

Biopharma Biotech Engineering Collaboration 52

Jake Jorgovan

NOVEMBER 15, 2023

Industries: Artificial Intelligence, Cloud Computing, Cybersecurity, Data Science, E-Commerce, Green Tech, Identity & Access Management, Internet of Things, Machine Learning, SoftwareBiotech, Biopharma, Computational Biology, Diagnostics, Genomics, Healthcare, Health Insurance, Medical Devices, Pharmaceuticals, TherapeuticsBanking, Blockchain, (..)

Life science 130

Life science Fintech Telecommunications Biopharma 130

LaVoie Health Science Blog

JULY 16, 2021

As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors. What are some of the unique considerations that biopharma and life science firms must consider in mapping out their ESG strategies? Enough said.

Life science 69

Life science Biopharma Biotech Biotechnology 69

LaVoie Health Science Blog

JULY 1, 2020

As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that public companies may encounter is aggressive moves by activist investors looking to leverage the economic turmoil for corporate takeovers.

Biotech 52

Biotech Life science Biopharma Value creation 52

Planview Blog

MAY 18, 2023

We were pleased to sponsor two occasions of the WHY Summit’s Annual Pharma & Biotech Project, Program, and Portfolio Management conferences in Basel, Switzerland , and Philadelphia, U.S. Find out how this long-standing biopharma company uses Planview Advisor’s advanced analytics capabilities to uncover R&D value.

Biopharma 52

Biopharma Life science Biotech Utilities 52